DnB Asset Management
ATOS icon

DnB Asset Management’s Atossa Therapeutics ATOS Stock Holding History

DnB Asset Management’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,040
Closed -$9.2K – 1236
2025
Q4 		$9.2K Hold
1,040
– – ﹤0.01% 731
2025
Q3 		$13.5K Hold
1,040
– – ﹤0.01% 731
2025
Q2 		$12.9K Hold
1,040
– – ﹤0.01% 716
2025
Q1 		$10.5K Hold
1,040
– – ﹤0.01% 735
2024
Q4 		$14.7K Buy
1,040
+13
+1% +$254 ﹤0.01% 731
2024
Q3 		$23.4K Buy
+1,027
New +$20.7K ﹤0.01% 714

Other funds holding ATOS

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

DnB Asset Management's ATOS Position: Q1 2026 in Review

DnB Asset Management sold out of Atossa Therapeutics (ATOS) in Q1 2026, closing a stake of 1,040 shares — an estimated $9.2K sold.

DnB Asset Management first reported a position in ATOS in Q3 2024 and held it in 6 quarters. The position peaked at $23.4K in Q3 2024. 33 funds tracked by Wall St. Rank hold ATOS as of Q1 2026.

  • DnB Asset Management reported no remaining Atossa Therapeutics position as of Q1 2026 after selling out during the quarter.
  • DnB Asset Management sold 1,040 Atossa Therapeutics shares in Q1 2026, an estimated $9.2K.
  • DnB Asset Management first reported a position in Atossa Therapeutics in Q3 2024 and held it in 6 quarters.
  • DnB Asset Management's Atossa Therapeutics position peaked at $23.4K in Q3 2024.
  • 33 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q1 2026.

Based on DnB Asset Management's 13F filing for Q1 2026, filed 14 May 2026.